{
  "schema_version": "1.0",
  "generated": "2026-05-14",
  "description": "Society/consortium abstract mock dataset (AASLD, EASL, KASL, APASL, DDW, NIT Workshop)",
  "abstracts": [
    {
      "abstract_id": "ABS-001",
      "society": "AASLD The Liver Meeting 2025",
      "title": "ELF score qualification for prognosis in MASH: final FDA BQP submission package",
      "session": "Late-breaking oral",
      "linked_biomarker": "BMK-001",
      "korean_authors": false,
      "importance": "high",
      "summary": "Final qualification rationale, AUROC 0.81 for advanced fibrosis, MALO surrogate justification"
    },
    {
      "abstract_id": "ABS-002",
      "society": "EASL ILC 2025 NIT track",
      "title": "FIB-4 + VCTE two-step pathway: EMA qualification opinion outcomes",
      "session": "Parallel session",
      "linked_biomarker": "BMK-003",
      "korean_authors": false,
      "importance": "high",
      "summary": "DeLIVER pragmatic cohort, NPV>90%, 60% biopsy reduction"
    },
    {
      "abstract_id": "ABS-003",
      "society": "KASL Annual Meeting 2026",
      "title": "한국인 MASLD/MASH 코호트에서 FIB-4 컷오프 재정의 (KASL-LITMUS-Korea 중간분석)",
      "session": "Plenary",
      "linked_biomarker": "BMK-036",
      "korean_authors": true,
      "importance": "high",
      "summary": "한국 다기관 n=2,140, AUROC 0.82, 한국 특이 컷오프 1.45 제안"
    },
    {
      "abstract_id": "ABS-004",
      "society": "APASL 2026",
      "title": "PNPLA3 GG genotype risk panel in Korean MASLD: KFDA pre-submission",
      "session": "Oral",
      "linked_biomarker": "BMK-048",
      "korean_authors": true,
      "importance": "medium",
      "summary": "KoGES 8,420명 PRS C-index 0.71, MFDS IVD 등동성 가능성"
    },
    {
      "abstract_id": "ABS-005",
      "society": "AASLD The Liver Meeting 2025",
      "title": "PathAI AIM-NASH: FDA BQP qualification for histology endpoint reading",
      "session": "Late-breaking oral",
      "linked_biomarker": "BMK-014",
      "korean_authors": false,
      "importance": "high",
      "summary": "Concordance kappa 0.62, multi-scanner repeatability ICC 0.91"
    },
    {
      "abstract_id": "ABS-006",
      "society": "LITMUS-NIMBLE Annual Symposium 2025",
      "title": "Composite imaging endpoint (MRE+cT1+MRI-PDFF): EMA QO submission rationale",
      "session": "Plenary",
      "linked_biomarker": "BMK-039",
      "korean_authors": false,
      "importance": "high",
      "summary": "AUROC 0.91 vs paired biopsy, non-invasive composite endpoint candidate"
    },
    {
      "abstract_id": "ABS-007",
      "society": "EASL-NIH NIT Workshop 2026",
      "title": "MEFIB qualification: PPV 0.97 rule-in for significant fibrosis MASH",
      "session": "Workshop session",
      "linked_biomarker": "BMK-028",
      "korean_authors": false,
      "importance": "high",
      "summary": "Sequential rule-in/rule-out workflow with MRE + FIB-4"
    },
    {
      "abstract_id": "ABS-008",
      "society": "NASH Investigator Forum 2025",
      "title": "MAST score: high-specificity diagnostic for fibrotic NASH",
      "session": "Symposium",
      "linked_biomarker": "BMK-005",
      "korean_authors": false,
      "importance": "medium",
      "summary": "NIMBLE imaging arm AUROC 0.93"
    },
    {
      "abstract_id": "ABS-009",
      "society": "KASL Annual Meeting 2026",
      "title": "한국 다기관 MRE bridging 연구: KFDA SaMD 동등성 평가 자료",
      "session": "Oral",
      "linked_biomarker": "BMK-022",
      "korean_authors": true,
      "importance": "high",
      "summary": "서울/부산/대구 380명 AUROC 0.91, MFDS Class III 후보"
    },
    {
      "abstract_id": "ABS-010",
      "society": "DDW 2025",
      "title": "SHIELD AI classifier for primary-care MASH screening: NIMBLE-DeLIVER external validation",
      "session": "Plenary",
      "linked_biomarker": "BMK-016",
      "korean_authors": false,
      "importance": "high",
      "summary": "External AUROC 0.84, EHR-deployable"
    },
    {
      "abstract_id": "ABS-011",
      "society": "AASLD The Liver Meeting 2025",
      "title": "Resmetirom companion biomarker panel: post-approval validation",
      "session": "Late-breaking",
      "linked_biomarker": "BMK-040",
      "korean_authors": false,
      "importance": "high",
      "summary": "Real-world MRI-PDFF + VCTE response classification"
    },
    {
      "abstract_id": "ABS-012",
      "society": "APASL 2026",
      "title": "Asia-Pacific MASLD biomarker validation: KASL/JSH/APASL bridging",
      "session": "Symposium",
      "linked_biomarker": "BMK-021",
      "korean_authors": true,
      "importance": "high",
      "summary": "ELF 동등성 + 한국 정상 reference range 제안"
    },
    {
      "abstract_id": "ABS-013",
      "society": "NASH Investigator Forum 2025",
      "title": "DDTII workshop: multi-omics fingerprint for MASH progression",
      "session": "Workshop",
      "linked_biomarker": "BMK-045",
      "korean_authors": false,
      "importance": "low",
      "summary": "Early discovery proteo-metabo-lipidomics signature"
    },
    {
      "abstract_id": "ABS-014",
      "society": "KASL Annual Meeting 2026",
      "title": "HIRA reimbursement evidence for FAST score: 한국 다기관 코호트",
      "session": "Policy track",
      "linked_biomarker": "BMK-023",
      "korean_authors": true,
      "importance": "high",
      "summary": "신의료기술평가 신청을 위한 RWE 패키지"
    },
    {
      "abstract_id": "ABS-015",
      "society": "EASL ILC 2025",
      "title": "ProC6/endotrophin as MALO prognostic biomarker: LITMUS outcomes",
      "session": "Oral",
      "linked_biomarker": "BMK-029",
      "korean_authors": false,
      "importance": "medium",
      "summary": "HR 1.8 per SD for major adverse liver outcomes"
    }
  ]
}